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Distinctive dendritic cell subsets expressing
factor Xllla, CD1a, CD1b and CD1c in
mycosis fungoides and psoriasis
The papillai")' dermis of psoriasis and mycosis fungoides (MF)
lesions is characterized by prominetit collections of cells widi
dendritic morphology. Immitnophetiotypically distinct pop-
ulations of cutaueous dendritic cells have been identified as
CDla-F, FXlIIa-Langerhans cells (LC) and CDla-, FXlIIa-t- det-
mal dendritic cells (DDC). In this study, antibodies agaiust the
human CDl eluster of autigeus (i.e. CDla, CDlb and CDlc)
and the DDC marker (FXIIIa) were used to fut ther character-
ize the subsets of dendritic cells in normal skin as compared
to neonatal foreskin, psoriasis and MF by both immunoperoxi-
dase and double immunofiuoresceuce techtiiques. Normal skin
and foreskin epidermis and dermis contained few CDlb4- or
CDlc-l- cells along with normal numbers of CDla+ LC; aud
FXIIla-F DDC. Both MF and psoriasis were eharacterized by
CDla+ cells in the epidermis and dermis. FXIIla-F cells were
gready expanded in the upper dermis of MF lesions aud to a
lesser degree iu psoriasis as has been previously desct ibed by
our gtoup. VIF coiitaitiecl signifieautly increased epidertiial
and dertiial CDlb-t- (15.7/5 high power fields [HPF] and
59.7/5 HPF respectively) aud CD1e+ dendritic cells (33.8/5
HPF and 95.9/5 HPF respectively), while iu psoriasis these
cells were not statistically different from normal skin. Double
immuuofiuore.scence studies revealed that sotne (<25%)
FXIIIa+ cells co-expres.sed CDlb and CDlc iu MF>psoriasis>
foreskiu, while FXIIIa+ DDC never co-expressed CDla. Thus,
iu couttast to nottnal skiu iu which epidermal or dermal deti-
dridc cells rarely express CDlb aud CDlc andgens, these
members of the CDl family are upregitlated on both LC aud
DDC' iu benign and malignant iullammatoiy states. Upregu-
lafion of CDib and CDlc on MF epidermal and dermal den-
dritic cells, as compared to psoriasis, foreskin aud normal skiu,
may be useiiii in the immimopheuotypic recognition of MF, as
well as in helping to understand its immuuobiology.
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A grcjwing l̂ ody of evidence is availai:)le regarding
thc> role of dermal dcudritic cells (DDC) (1). We
have described ptoiiiinent collections these cells
(defitied by factor Xllla expre.ssioti) in lesional
skin from mycosis fungcDides (MF), psoriasis aud
allergic contact dermatitis (2-5). Data from several
laboratories have shown that DDC express a variety
oCstirfacc antigetis iticluding: Thy-1, FXIlla, ('DM,
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.EBM-ll, C]D36, C^Dllb, and CDllc, suggesting
they are related to blcjod-clerivecl monocytes
and/or dssiie macrophages (6-10). Despite this
immunophenotyping data, the exact relationship
between the varicius epidermal and dermal den-
dridc cells remains to be elucidated (1, 2). Re-
cently, protocols for purification of DDC] have re-
vealed that there are several subsets ideutiliable
aud that these cells are efficient antigen preseutitig
cells which selectively activate Thl-type T cells (11,
12).
CjDIa, C]DIb atid C^Dlc antigetis have been ideti-
tified as markers for several of these cutaneous
antigen presetititig cells iti bettigti licliencjid der-
matoses such as lichen platiits, alletgic eotitact der-
matitis and atopic dertnatitis (3, 14). C'Dlc has also
been shc:)wn to be expressed by dermal endothelial
cells (13). In this report, we have studied the clistti-
butiou of antibodies which differentiate CDl clus-
ter of antigens (C]Dla vs CDlb vs CDlc) in rela-
tionship tc:) FXIIIa iu both the epidermal and der-
mis by immunostaining a seties of specimens from
normal adult skin, neonatal foreskin and un-
treated MF and psoriasis. We repcDrt that normal
skiti aticl fcjreskin contains rare CDlb-l- or CDlc-F
deudiitic cells similar to previous reports (13, 14).
In contrast, epidermal and dermal CDlb-l- and
CDlc-t- dendritic cells were regularly seeu in both
psoriasis and MF, FXIIIa+ DDC] were found to be
increased in both MF and psoriasis as we have
previously sliowu. A prominent tuinoi ity oi these
cells are slu:)wn to co-express CDlc and CDlb, but
nc3t C]Dla, in diseased skin only.
Material and methods
Patient.s — Punch biopsies frotn 16 patients with
untreated MF (6 patch aud 10 placiite-stage pa-
tieuts) and 9 patietits witli itntteated plaque-type
psoriasis were obtaitied alter informed ec:)nseut at
the titne ot diagnostic biopsy procedure. Normal
skin (uoti-sitti exposed, ti = 7) specimens were c:)b-
tained from buttock skin ot healthy volimteets.
Neouatal foreskins (n =11) were c:)btained within 4
h of circumcision from the newborn nut-sety. All
specimens were obtained under IRB approved ]Dt c3-
tocols at Henty Fotd Hospital and the University oi'
Miehigan Medical Cetiter.
Imm-u/nohislochcmistiy - 1 limitttioperoxiclase staitiitig
was perfottned on ait-dried, ac:etotie-rtxed, 4-tiii-
cron tliick ciycjstat sections of all specimetis. Serial
sections were exposed to primaty atitibodies for
one hour. Antibodies were visualized using au avi-
din-biotiti itmiiutiopcroxidase staiuitig teelmique
(Vectastain ABC- Kit, Vector Labs Iue., Burliiigatne,
CA) as previou.sly described (4). The chtotnageti
itsed was 3-atiiitio, 9-ethylcarbazc:)le (AEC-Sigma
C]c:)., St. Louis, MO). All sectic:)iis were coimler-
stained with 1% heiiiatoxyliti. Ati irrelevatit, iso-
type-matched antibody (atiti-tniirine laP or anti-
human FXIIIs) was included with each set of pa-
tient slides as a control.
The antibodies were diluted iti phosphate bui-
ferecl salitie (PBS) with 0.5% bovitie serum albu-
min (BSA-Sigina) and included: atiti-hiitnan C^Dla
(1:200), C]D'lb (1:25), CDlc (1:50) (Biodesign,
Ketmebuukport, MF), anti-faetor Xllla (1:400),
anti-factor Xllls (1:400) (C^albiochem, LaJoUa,
C]A). Ptelitninaty experiments on reactive lytnph
node and nortnal skin specimetis were perl'ortned
\.o cletettnitie the optittial dilutioti for each atiti-
body. Atiti-mttritie laP-elass 11(1:50) was used as ati
isotype control (Acctttate Chetiiieals, Iue., West-
buiy. New York).
Dotible immunofluorescence — Fout^-micron thick
cryostat sections were fixed in cold acetc:)ue for ten
minutes and air dried. Primaiy andbodies (diluted
using PBS with 0.5% BSA) were mouse anti-human
CDla (1:100), C^Dlb (1:10), CDlc (1:25) and t-ab-
bit anti-htitnati factor Xllla (1:200). The.se were
applied and incubated at tootii tetnperature for 45
tiiin. I h e slides were washed fot̂  10 tiiiti in PBS,
aud labeled secoudaty antibodies (goat anti-
mouse-FITC]) (Dakcj-1:4()) atid goat anti-rabbit-rho-
datnine (C]albic:)chem-1:20) were applied tor 45
min. C>ontrols included deletion of one or both
primaiy antibodies, a n d / o r one or both secondary
antibodic;s.
All sections were examined by light tnicroscopy,
and the liumbet s of reactive cells for each mouo-
clotial atilibody recorded. Qttatititatioti was limited
to cells of detidt itie tncjrpholog)' iu MF, psoi iasis,
tiot tnal skiti and foreskin iu all staitiitig studies aud
was performed by coitnting all cells reactive with
the antibody in at least live consecutive 40x high
pcjwer fields (HPF) of contiguous epidermis aud
dermis atid expressed as tiieati ± SEM/5 HPF.
Statisticcd analysis — Pairwise comparisons (Wil-
coxoti tests) were made of the epidermal atid det-
tiial exptession c:)f Cf)la vs CDlb vs C^Dlc betweeti
MF (patch atul plaque stage satii|:)les wete eval-
itated separately and as c:)ne group), psotiasis, \\o\~-
tiial skin aud tieotiatal foreskin. Descriptive statis-
tics wete pet lotnied itsiug the Kiaiskal-WalHs test.
Statistically signiftcaut differetices betweeti the
6 paitwise couipatisoti tests wete deiitied as p
< 0.0083 after Botifet toui's adjusttnetit for the
comparison ot tiitiltiple groitps.
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MF = Mycosis tungoides, PS=Psoriasis, NS=Normai aduit skin, FS=Neonatal foreskin
= mean ± SEM of 5-consecutive high power fields in the epidermis or dermis
** = statisticai significance increase in fViF vs foreskin, p < 0.0083 after Bonferroni's adjustment on the rejection level for the pairwise comparison of 6 Wllcoxon fests
" * = statisticai signiticance increase in MF vs NS and foreskin but not PS, p < 0.0083 after Bonferroni's adjustment on the rejection level for the pairwise comparison
of 6 Wilcoxon tests





for the expression of CE)la, C]Dlb and C^Dlc anti-
gens on dendritic cells in MF, psoriasis atid tiortnal
skin are summarized in Table 1. Normal skiti was
found tc5 contain rare epidermal atid det tnal
CDlb-F or CDlc-f deudtitic cells, while C]Dla-t- epi-
dermal and dermal cells were found in propor-
tions comparable to prior reports (14—16). Epider-
mal CDlb-l- aud CDlc-f cells were rarely seen in
tiortnal skiti and foieskitt s|3eeitiietis. Those ob-
served were fouticl in a suprabasal location atid had
prc:)tniuent cletidritie ptoeesses. Foreskitis tended
to have greater titttnbers of C]Dlc-f cells thatt tior-
mal skin, but these iuuiil:)ets wete uot statistieall)'
significant (Fig. la).
CDlb-t- dendritic cells were sigtiiiicatith' iu-
creasecl iu the epidermis aud dei'inis ol'MF lesiotis
in eouipat isoti \.o l'c:)reskiu (p< 0.083) but were
ittc:reased in couipari.soti to psoriasis
and normal skiu (p = 0.021 aud p = 0.023 respec-
tively) (see Table 1 and Fig. lb). C:Dlc-h dertual
dendritic cells were statistieall)' iticteased
(p< 0.0083) in MF as compared to psoriasis, nor-
mal skin and/or foreskin specimens (Fig. \c:).
CDlc-F epidermal cells wete also statistically in-
creased in MF as compared to uormal skin and
foreskiu (p< 0.0083) but only marginally increased
in comparison to psoriasis (p = 0.02) (see Table I
and Fig. Id). When analyzed separateh', there were
uo ap]Dreciable differetices iti the tueati tnunbers
of C;Dlb-t- or C]Dlc-t- deudtitic cells between patcb
aud plaque stage MF specitneus, therel'ote all sta-
tistical tesults reptesetit the composite findings
from the enfire group of 16 MF patietits.
LC] were tegularly idetiUlied iu all speciuietis as
C]Dla+ dendritic cells iti a suptaba.sal ei^idettiial
lc:)eatic:)n, iDiit were ucjt sigtiificatitl)' increased iu MF
as cc:)mpared to normal skiti, as previously obsetTcd
(I5,i6). CD 11)+ atid CDic-t- cleuciritic cells were
also seeti iti both cotnparltuetits iti psotiasis (Fig.
Id) bitt were uot statisticalh' increased iti ccMiipati-
sou to foreskin or tioruial skiu uttnil:)ets of cells. It
could not be determined if C]Dlb-F or C]Dle-l- epi-
dermal cells appreeiably colocalized with C];Dla-f
cells in serial sections. C]Dla+ deudritie eells in the
dertiiis of MF were significantly increased over
thc:)se in psoriasis, normal skin and foreskin dertnis
(p<0.0083, see Table I). CDla-F epidetmal aud
dertnal cells iu psoriasis were not signifieantly dii-
fetent from iic:)rmal skin.
As ccMiipared \o the niitnbers of FXllla-i- dermal
deudritie cells obser\'ed iu nortnal skiu (20-40/
5 HPF) or tieonatal foreskiu (30-60/5 HPF), FX-
IIIa+ detidtitie cells were greatly expanded iu the
upper det tliis of MF lesions (100-300/5 liigh
pc:)W'er iieldsfHPF]) and iu psoriasis (50-70/5
HPF). The laP and EXIIls i.sotype conttols were
negative iu all expei itiietits (results uoi slio\vu). No
FXIIla+ eells wet e l'outid iu the epidertnis of any
speeimen.
Double imnmnofhwrescence staining- Double IF stud-
ies were perfotnied on all pafient speeimens.
10-25% of the FXIIIa-F DDC] were found to co-
express C]D]c-f in both MF and psoriasis, while few
(<10%) FXIIIa+ DDC co-expressed CDlb in both
MF aud psoriasis. Precise quantification \vas not
possible due to the extensive dendridc atboriza-
tious present throughout the iufiammatoiy lesions
of MF and psoriasis (Fig. 2a, 2b). No FXIIla-F eells
were i'cniud to eoexpress CDla iti uot tnal skiti.
loteskiti, MF or psoriasis.
Discussion
'fhis stttdv deuionstrates that deudt-itie cell pop-
ulatiotis iti both epidetmal atid detuial skiu com-
pat tmetits cau expte.ss of C]D11) atid CU)lc andgeus
iu iuilatntnatof)' stales. We have showu that ejiider-
tual C;i)lb-F aud (]Dlc-t- deudtitic cells were tarely
iotuid iu uormal achth si^iu i)ut \vere regularlv rec-
ogtiized itt MF atid ji.soriasis. C]l)la+ LC] atid FX-
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Fig. 1. Immunoperoxidase staining of CDlb-F and CDlc+ dendritic cells in foreskin epidermis and dermis (Fig, la-CDlc, x50),
plaque stage mycosis fungoides (Eig. lb-CDlb, x,50; Eig, lc-CDlc, x50) dendritic cells and in lesional psoriasis (Eig, ld-CDlc, x50).
There are several prominently stained dendritic cells in the dermis as well as in the epidermis in both Eigs, lb and lc. Mycosis
fungoides was found to have the greatest increase in CDlc-^ epidermal and dermal dendritic cells compared to normal skin (see
text),
Fig. 2. Double immunofltiore,sence labelting of dermat dendritic cells in plaque stage mycosis fungoides. Fig, 2a-A CDlc-F dendritic
cell is stained green with the fluoresceinated secondary antibody (100). Eig, 2b-The same cell is also EXIIla-F and stains red with the
rhodamine labeled secondary antibody (lOOX). Note the prominent dendritic processes are present in both panels demonstrating
co-expression by the identical cell.
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Illa-l- DDC were also found to be increased in MF,
as previously reported (4,6). These increases coin-
cided with statistically increased numbers of
CDlb-i- and CDlc-f dendritic cells in both the epi-
dermis and dermis as compared to normal skin
and/or neonatal foreskin.
A subset of FXIIIa-i- dermal dendritic cells in all
cases of MF, psoriasis and foreskin were found to
co-express CDlc-i- and to a lesser degree CDlb-f,
yet never expressed CDla. CDlb-i- and CDlc-i- FX-
IIIa-l- DDC were rarely seen beyond their routine
perivascular location in normal adult skin. Dermal
co-expression of FXIIIa and CDl cluster antigens
beyond CDla (i.e. CDlb and/or CDlc) by den-
dritic cells in psoriasis and MF suggests that there
are distinct subsets of dermal dendritic cells tbat
become apparent under certain infiammatoiy and
neoplastic conditions (14). Unique immunophe-
notypes appear to exist in epidermal vs dermal
compartments, as co-expression of CDla and FX-
IIIa was not shown. Thus, although similar in mor-
phology, DDC remain as distinct from LC. Re-
cently, subpopulations of dermal dendi'itic cells
have been isolated from psoriasis and normal skin
and a CD14-t-, FXIIIa-f, CDla-l- subset was found in
vitro ( l i , 12).
These data give no direct insights into the func-
tional properties of DDC vs. LC. However, CDl
antigens have been shown to resemble HLA- Class
lb molecules which are selectively involved in anti-
gen presentation to CD8-I- cells (15). Physiologic
upregulation of these CDl antigens in fetal and
neonatal skin could help in generation of self-
tolerant clones of CD8-f cells. Aberrant CDlb or
CDlc expression by dendritic cells in MF and pso-
riasis might be a mechanism through which auto-
reactive signals are generated which allow disease
progression or a mechanism through which cyto-
toxic T cell are generated locally. Taylor et al.
recently reported CDlb and CD36 "aberrantly" ex-
pressed by epidermal LC as well as CDla-l-, CDlb-(-,
CD36-I-, HLA-DR+ dermal cells in association with
increased auto re activity in atopic dermatitis (9).
CDla-, CD36-t- macrophages in man and Thy-l-l-
dendritic epidermal T cells in mice have also been
reported to possess this type of suppressor-inducer
function in vitro (9, 17-20).
While the function of FXIIIa+ DDC is unknown ,
this study demonstrates that certain subsets of epi-
dermal and dermal dendritic cells are interrelated
immunophenotypically, CDlb and CDlc expres-
sion by FXIIIa-i- DDC, wbile rare in normal skin, is
shown to be more common in infiammatory skin
conditions. We speculate that, in T cell-mediated
skin disease (e.g, psoriasis and MF), some un-
known stimulus is fiinctioning to regulate CDlb
and CDlc expression on both DDC and LC. The
mediators which regulate dendritic cell expression
of CDl cluster antigens are currently under in-
vestigation. The upregulation of CDlb and CDlc
expression in all lesional MF specimens on epider-
mal and dermal dendritic cells demonstrated here
as compared to psoriasis, foreskin and normal skin,
may be useful in the immunophenotypic recog-
nition of MF, as well as in helping to understand its
immunobiology.
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